Trevi Therapeutics, Inc. TRVI
13.63 USD +0.07 +0.52%
At close · Nov 2
13.63 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
- Open
- 13.70
- Prev close
- 13.56
- Mkt cap
- 1.94B
- Vol
- 1.47M
- Avg vol
- 1.95M
- EPS
- -0.35
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 13.21
- High
- 13.81
- Forward P/E
- -23.62
- Beta
- 1.12
- Short ratio
- 5.94
- Inst. own
- 109.88%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 12, 2026
- 50-d avg
- 14.69
- 200-d avg
- 14.34
- 1y target
- 28.18
MAX chart
Chart tools
Chart is warming up
The all-time price history for TRVI has not been loaded yet. Try again in a moment.
Altman Z-Score
126.60 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 5
- P/E 1
- P/B 1
P/E -43.2×
P/S 0.0×
P/B 9.9×
P/FCF -43.2×
EV/EBITDA -42.1×
EV/Sales 0.0×
FCF Yield -2.3%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -23.3%
ROIC -26.8%
ROA -22.1%
Revenue 0.0%
Operating Income 4.3%
EPS (diluted) 38.3%
Free Cash Flow -10.0%
Current Ratio 19.7×
Quick Ratio 19.7×
Debt / Equity 0.0×
Net Debt / EBITDA 0.4×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31